International Journal of Medical Sciences

The optimization of supplementary long-term oxygen therapy (LTOT) to correct resting, nocturnal, and exertional hypoxia, diuretics and identification and treatment of contributing factors, such as OSAS, is crucial. There are currently no approved therapies for the treatment of PH in IPF patients. ................
................